Neonatal Jaundice Management

Diagnostic Tests

The American Academy of Pediatrics recommends blood type and direct antibody test (Coombs') if hemolysis is suspected, as well as urine tests for reducing substances in patients with suspected hemolytic disease 1
Reticulocyte count, haptoglobin, and LDH levels should be checked if hemolysis is suspected, according to the Pediatrics guideline 1
Perform additional laboratory tests, including complete blood count, liver function tests (ALT, AST, ALP, GGT), coagulation studies (PT/INR), serum albumin, and protein, to evaluate the underlying cause of elevated bilirubin 2
Evaluate for hemolysis by reviewing CBC for anemia and elevated reticulocyte count, and consider peripheral blood smear, haptoglobin, and LDH 3

The Pediatrics guideline recommends IV immunoglobulin (0.5-1 g/kg over 2 hours) for immune hemolytic disease if total bilirubin is rising despite intensive phototherapy or within 2-3 mg/dL of exchange level 1
Exchange transfusion is recommended for severe cases of hemolytic disease, and should be performed only by trained personnel in the NICU, as per the Pediatrics guideline 1
For hepatitis B, nucleos(t)ide analogues or interferon-based regimens are recommended by the European Association for the Study of the Liver 4
For hepatitis C, direct-acting antivirals are recommended by the European Association for the Study of the Liver 4
For drug-induced hyperbilirubinemia, discontinuing the offending medication is recommended, with permanent discontinuation for ALT >8× ULN with bilirubin >2× ULN, and consideration of dose reduction or temporary interruption for ALT 5-8× ULN with normal bilirubin, as recommended by the European Society for Clinical Gastrointestinal Endoscopy 5

The Pediatrics guideline advises against relying solely on visual estimation of jaundice, as this can lead to errors, particularly in patients with darker skin pigmentation 1
Total bilirubin levels ≥25 mg/dL (428 μmol/L) require immediate hospital admission for intensive phototherapy, according to the Pediatrics guideline 1
The Pediatrics guideline recommends not subtracting direct bilirubin from total bilirubin when using guidelines for phototherapy and exchange transfusion 1
Periodic monitoring of bilirubin levels and reassessment of albumin levels are necessary to track improvement, as recommended by the American Gastroenterological Association 2
Elevated bilirubin is a reliable prognostic marker as liver cirrhosis advances to decompensation, and becomes a significant predictor of disease progression, according to the American Association for the Study of Liver Diseases 6

Use abdominal ultrasound as first-line imaging, which is highly sensitive (65-95%) for liver parenchymal disease and has variable sensitivity (32-100%) for biliary obstruction, as recommended by the American College of Radiology 7
If bile ducts are dilated on ultrasound, consider MRCP or CT for further evaluation, and ERCP should be considered if therapeutic intervention may be needed 8
Advanced imaging with MRI and MRCP is recommended to evaluate for early primary sclerosing cholangitis or primary biliary cirrhosis, despite normal ultrasound findings, as suggested by the American College of Radiology 8
The normal range for direct bilirubin is typically less than 0.3-0.4 mg/dL, as suggested by the American Academy of Pediatrics 1
Direct-reacting bilirubin is not exactly the same as conjugated bilirubin, and includes both conjugated bilirubin and delta bilirubin (bound to albumin), as clarified by the American Academy of Pediatrics and the European Association for the Study of the Liver 1, 3
The ratio of direct to total bilirubin provides more clinical information than the absolute value alone, and should be considered when evaluating direct bilirubin levels 1